POMPANO BEACH, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) — BioStem Technologies Inc. BSEM, a number one MedTech firm centered on the event, manufacture, and commercialization of placental-derived biologics for superior wound care, pronounces it’ll provoke a nationwide launch of Vendaje AC® with Venture Medical, LLC, the Firm’s unique gross sales and advertising and marketing companion. The launch is scheduled to begin within the fourth quarter and can cowl each Medicare Administrative Contractor (MAC) area throughout the US.
Jason Matuszewski, CEO of BioStem Applied sciences Inc., commented: “This can be a pivotal second for BioStem Applied sciences. With nationwide Medicare reimbursement, Vendaje AC® turns into our second product accessible to sufferers throughout all 50 states. The launch of Vendaje AC® underscores our dedication to delivering modern wound care options for sufferers affected by continual, non-healing wounds. We’re excited to collaborate with Enterprise Medical as soon as once more, whose partnership was instrumental within the success of AmnioWrap2®. Collectively, we’re increasing entry to cutting-edge therapies that make an actual distinction in affected person outcomes.”
John Schroeder, CEO of Enterprise Medical, LLC, added: “With numerous graft merchandise accessible right now, we’re proud to companion with BioStem Applied sciences, an organization that prioritizes medical efficacy in all the things they do. Vendaje AC®, manufactured utilizing the modern BioREtain® course of, retains the crucial parts of placental tissue—structural elements, progress elements, and anti inflammatory cytokines—which are important for efficient wound therapeutic. This breakthrough permits us to supply healthcare suppliers and Medicare beneficiaries a robust, reimbursable answer tailor-made to fulfill the wants of sufferers with non-healing wounds. Collectively, we’re bringing a significant answer to those that want it most.”
About Vendaje AC®:
Obtainable by prescription via healthcare suppliers in all 50 states, Vendaje AC gives sufferers with non-healing wounds a sophisticated wound care choice that acts as a protecting barrier or protecting to offer an atmosphere for wound therapeutic and closure. Vendaje AC is a thicker human connective tissue matrix comprised of dehydrated amniotic/chorionic tissue. Manufactured utilizing BioStem’s patented six-step proprietary BioREtain® course of, Vendaje AC naturally accommodates extracellular matrix scaffolding, which gives mechanical safety and useful assist for cell attachment, progress elements that assist modulate proliferation and angiogenesis, and cytokines that inhibit inflammatory results, all of that are crucial in aiding the physique’s pure therapeutic cascade.
Healthcare suppliers or sufferers considering studying extra about Vendaje AC allografts can go to: https://biostemtechnologies.com/vendaje-ac-2/ .
Be a part of BioStem’s Distribution Record & Social Media:
To comply with the newest developments at BioStem, sign-up to the Firm’s e-mail distribution checklist HERE , and comply with us on Twitter and LinkedIn.
About BioStem Applied sciences, Inc. BSEM:
BioStem Applied sciences is a number one innovator centered on harnessing the pure properties of perinatal tissue within the improvement, manufacture, and commercialization of allografts for regenerative therapies. The Firm is targeted on manufacturing merchandise that change lives, leveraging its proprietary BioREtain ® processing technique. BioREtain ® has been developed by making use of the newest analysis in regenerative drugs, centered on sustaining progress elements and preserving tissue construction. BioStem Applied sciences’ high quality administration system and customary working procedures have been reviewed and accredited by the American Affiliation of Tissue Banks (“AATB”). These techniques and procedures are established per present Good Tissue Practices (“cGTP”) and present Good Manufacturing Processes (“cGMP”). Our portfolio of high quality manufacturers contains AmnioWrap 2 ™, VENDAJE ® , VENDAJE AC ® , and VENDAJE OPTIC ® . Every BioStem Applied sciences placental allograft is processed on the Firm’s FDA registered and AATB accredited website in Pompano Seaside, Florida.
For extra data go to biostemtechnologies.com and comply with us on Twitter and LinkedIn.
About Enterprise Medical, LLC:
Enterprise Medical is a groundbreaking healthcare companies firm with a decade-long historical past of innovation, dedication, and constant progress within the subject of wound care and therapeutic. Over the previous 15 years, Enterprise Medical has expanded its attain throughout the US and has grown to turn into a number one grasp distributor and reseller and software program companies supplier for producers and finish customers of biologics, superior diagnostics, sturdy medical gear, and capital items.
For extra data, go to www.venturemedical1.com and comply with us on LinkedIn.
Ahead-Wanting Statements:
Apart from statements of historic reality, this launch additionally accommodates forward-looking statements throughout the which means of the Non-public Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts of future occasions. Ahead-looking statements could also be recognized utilizing phrases comparable to “forecast,” “intend,” “search,” “goal,” “anticipate,” “consider,” “count on,” “estimate,” “plan,” “outlook,” and “venture” and different comparable expressions that predict or point out future occasions or traits or that aren’t statements of historic issues. Ahead-looking statements with respect to the operations of the Firm, methods, prospects and different elements of the enterprise of the Firm are primarily based on present expectations which are topic to identified and unknown dangers and uncertainties, which may trigger precise outcomes or outcomes to vary materially from expectations expressed or implied by such forward-looking statements. These elements embody, however should not restricted to: (1) the impression of any modifications to the reimbursement ranges for the Firm’s merchandise; (2) the Firm faces important and persevering with competitors, which may adversely have an effect on its enterprise, outcomes of operations and monetary situation; (3) fast technological change may trigger the Firm’s merchandise to turn into out of date and if the Firm doesn’t improve its product choices via its analysis and improvement efforts, it might be unable to successfully compete;(4) to be commercially profitable, the Firm should persuade physicians that its merchandise are secure and efficient options to present therapies and that its merchandise ought to be used of their procedures; (5) the Firm’s skill to boost funds to broaden its enterprise; (6) the Firm has incurred important losses since inception and should incur losses sooner or later; (7) modifications in relevant legal guidelines or rules; (8) the chance that the Firm could also be adversely affected by different financial, enterprise, and/or aggressive elements; (9) the Firm’s skill to take care of manufacturing of its merchandise in adequate portions to fulfill demand; and (10) the COVID-19 pandemic and its impression, if any, on the Firm’s fiscal situation and outcomes of operations; You might be cautioned to not place undue reliance upon any forward-looking statements, which converse solely as of the date made. Though it might voluntarily accomplish that every now and then, the Firm undertakes no dedication to replace or revise the forward-looking statements, whether or not on account of new data, future occasions or in any other case, besides as required by relevant securities legal guidelines.
BioStem Applied sciences, Inc.
Telephone: 954-380-8342
Web site: http://www.biostemtechnologies.com
E-Mail: [email protected]
Twitter: @BSEM_Tech
Fb: BioStemTechnologies
PCG Advisory
Jeff Ramson
[email protected]
646-863-6893
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
